Thomas Coates, MD
Pediatric Hematology-Oncology · Los Angeles, CANPI 1790885697
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Bristol Myers Squibb at 36.0% of the total. Reporting peaked in 2019 at $21,956 and has fallen 73.3% since, to $5,864 in 2025. Among pediatric hematology-oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $1227.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$36K
- Chiesi USA, Inc.$33K
- Agios Pharmaceuticals, Inc.$21K
- Vifor (international) Ltd.$4K
- Apo-pharma Inc.$3K
- E.r. Squibb & Sons, L.L.C.$2K
- plus $211 from 4 others
Across 23 payments — averaging $84,964 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$1.9M
- E.r. Squibb & Sons, L.L.C.$15K
What the payments were for
- Consulting fees$52,62053%
- Speaking & faculty fees$31,49332%
- Travel & lodging$8,0538%
- Food & beverage$1,6262%
- Education$5,6056%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 20 | $35,765 |
| Chiesi USA, Inc. | 21 | $32,605 |
| Agios Pharmaceuticals, Inc. | 29 | $20,517 |
| Vifor (international) Ltd. | 4 | $4,439 |
| Apo-pharma Inc. | 1 | $3,360 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,500 |
| Novo Nordisk | 2 | $154 |
| Global Blood Therapeutics, Inc. | 1 | $24 |
| Portola Pharmaceuticals, LLC | 1 | $20 |
| Sobi, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$99,396 in reported general payments places this provider in the 95th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric hematology-oncology in Los Angeles
- Noah FedermanLos Angeles$399K
- Jan van TornoutLos Angeles$137K
- Andrew DietzLos Angeles$88K
- Geetha PuthenveetilLos Angeles$62K
- Hisham Abdel AzimLos Angeles$52K
- Michael PulsipherLos Angeles$45K
- Leo MascarenhasLos Angeles$35K
- Edward GompertsLos Angeles$28K
- Paibel Aguayo-HiraldoLos Angeles$21K
- Paul GaynonLos Angeles$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.